First-line biologic therapy with tumor necrosis factor inhibitors for psoriatic arthritis: a prospective observational study.
Michael Ruberson Ribeiro da SilvaJéssica Barreto Ribeiro Dos SantosAdriana Maria KakehasiAlessandra Maciel AlmeidaPedro Ricardo Kömel PimentaJuliana Álvares TeodoroFrancisco de Assis AcurcioPublished in: Sao Paulo medical journal = Revista paulista de medicina (2022)
TNF inhibitor therapy was effective and safe. However, despite improvements in clinical measures, most patients did not achieve satisfactory control of the disease.